CFMS News and Press, Conformis Inc. From 02/19/20

BILLERICA, Mass., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific knee and hip joint replacement implants designed to...

BILLERICA, Mass., Feb. 05, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture, and sell patient-specific knee and hip joint replacement implants designed to fit...

Conformis - An Update on the Total Hip System I recently attended the first surgeon meeting for the recently launched Conformis (CFMS) total hip system that took place in Atlanta, Georgia. This is the first of several monthly meetings the company has scheduled to educate surgeons about t...

BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell patient-specific knee and hip joint replacement implants designed to fit ...

Executive Summary Alphatec Holdings, Inc. ( ATEC ) is a medical technology company that designs, develops, and markets products for the surgical treatment of spine disorders. The stock has skyrocketed about 400% over the last year predicated on the new management team, mainly its CEO, ex-NuV...

The following slide deck was published by Conformis, Inc. in conjunction with this Read more ...

ConforMIS (NASDAQ: CFMS ) announces preliminary Q4 and FY 2019 revenue results. More news on: Conformis, Inc., Healthcare stocks news, Read more ...

BILLERICA, Mass. and SAN FRANCISCO, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants designed to fit each patient ...

Athenex ( ATNX ) stock tumbled as it released pivotal trial results for its lead drug candidate, an experimental combination treatment for metastatic breast cancer. The Phase 3 trial tested oral paclitaxel along with encequidar, an inhibitor that aims to make chemotherapies more effective. T...

This article takes a look at the best-performing small-cap stocks with a list that presents an interesting group of emerging companies that are fast-growing or have attracted significant bullish sentiment based on a strong outlook. We take the Russell 2000 ( IWM ) constituents as our univers...